Eli Lilly and Co (LLY)
731.88
-13.81
(-1.85%)
USD |
NYSE |
Apr 24, 16:00
730.00
-1.88
(-0.26%)
After-Hours: 16:31
Eli Lilly Total Return Price: 731.88 for April 24, 2024
Total Return Price Chart
Historical Total Return Price Data
Date | Value |
---|---|
April 23, 2024 | 745.69 |
April 22, 2024 | 731.33 |
April 19, 2024 | 726.31 |
April 18, 2024 | 745.95 |
April 17, 2024 | 750.77 |
April 16, 2024 | 746.74 |
April 15, 2024 | 750.77 |
April 12, 2024 | 751.64 |
April 11, 2024 | 759.59 |
April 10, 2024 | 761.98 |
April 09, 2024 | 757.24 |
April 08, 2024 | 777.29 |
April 05, 2024 | 784.21 |
April 04, 2024 | 768.08 |
April 03, 2024 | 775.99 |
April 02, 2024 | 763.96 |
April 01, 2024 | 760.55 |
March 28, 2024 | 777.96 |
March 27, 2024 | 778.18 |
March 26, 2024 | 774.90 |
March 25, 2024 | 773.14 |
March 22, 2024 | 770.61 |
March 21, 2024 | 770.26 |
March 20, 2024 | 772.86 |
March 19, 2024 | 772.78 |
Date | Value |
---|---|
March 18, 2024 | 762.66 |
March 15, 2024 | 754.17 |
March 14, 2024 | 760.73 |
March 13, 2024 | 757.84 |
March 12, 2024 | 754.95 |
March 11, 2024 | 734.37 |
March 08, 2024 | 762.14 |
March 07, 2024 | 780.16 |
March 06, 2024 | 779.77 |
March 05, 2024 | 777.59 |
March 04, 2024 | 792.28 |
March 01, 2024 | 782.12 |
February 29, 2024 | 753.68 |
February 28, 2024 | 757.64 |
February 27, 2024 | 765.00 |
February 26, 2024 | 771.92 |
February 23, 2024 | 769.54 |
February 22, 2024 | 769.64 |
February 21, 2024 | 745.91 |
February 20, 2024 | 755.66 |
February 16, 2024 | 782.06 |
February 15, 2024 | 757.78 |
February 14, 2024 | 757.31 |
February 13, 2024 | 741.67 |
February 12, 2024 | 735.97 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
99.43
Minimum
Jul 19 2019
792.28
Maximum
Mar 04 2024
283.90
Average
238.88
Median
Total Return Price Benchmarks
Amgen Inc | 273.12 |
Biogen Inc | 202.13 |
Madrigal Pharmaceuticals Inc | 204.69 |
Vertex Pharmaceuticals Inc | 400.73 |
Viking Therapeutics Inc | 65.05 |